Cargando…
Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence
OBJECTIVE: Adalimumab has proven effective in psoriasis; however, secondary failure may result from the drug's immunogenicity. Prevalence data on the immunogenicity of biologicals, and of adalimumab in particular, are highly variable. We investigated the prevalence of anti-adalimumab antibodies...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168630/ https://www.ncbi.nlm.nih.gov/pubmed/27940624 http://dx.doi.org/10.1136/bmjopen-2016-011941 |